How can we do pharmacokinetic studies in the tropics?
Information regarding the pharmacokinetic (PK) and pharmacodynamic (PD) properties of a drug provides the basis for optimizing dosing. PK-PD information should be obtained from patients representative of the overall target population, but in many tropical hospitals or health care facilities it may b...
Saved in:
Main Authors: | Julie A. Simpson, Leon Aarons, Nicholas J. White |
---|---|
Other Authors: | University of Aberdeen |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/26594 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Towards optimal design of anti-malarial pharmacokinetic studies
by: Julie A. Simpson, et al.
Published: (2018) -
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
by: Kris M. Jamsen, et al.
Published: (2018) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
by: Kris M. Jamsen, et al.
Published: (2018) -
Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
by: Nicholas J. White
Published: (2018) -
How do patients use antimalarial drugs? A review of the evidence
by: Shunmay Yeung, et al.
Published: (2018)